Investigating biomarkers and regulatory mechanisms associated with depression and anxiety in obesity based on transcriptome sequencing and experimental validation
This study identifies CPOX and SLC35F5 as key downregulated biomarkers for depression and anxiety in obesity through integrated bioinformatic analysis and experimental validation, revealing their association with Toll-like receptor signaling and proposing subtype-specific therapeutic candidates like mazindol and FK-866.